tiprankstipranks
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
US Market

Guided Therapeutics (GTHP) Income Statement

Compare
24 Followers

Guided Therapeutics Income Statement

Last quarter (Q3 2024), Guided Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Guided Therapeutics's net income was $-654.00K. See Guided Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 98.00K$ 13.00K$ 81.00K$ 102.00K$ 36.00K
Gross Profit
$ 36.00K$ -68.00K$ 20.00K$ 61.00K$ -34.00K
Operating Expenses
$ 3.49M$ 3.27M$ 2.38M$ 1.20M$ 903.00K
Depreciation and Amortization
$ 85.00K$ 72.00K$ 1.00K$ 21.00K$ 21.00K
EBITDA
$ -3.13M$ -3.69M$ -919.00K$ 777.00K$ -488.00K
Operating Income
$ -3.46M$ -3.33M$ -2.36M$ -1.05M$ -937.00K
Other Income/Expenses
$ -32.00K$ -1.01M$ 292.00K$ 773.00K$ -984.00K
Pretax Income
$ -3.49M$ -4.34M$ -2.07M$ -279.00K$ -1.92M
Net Income
$ -3.49M$ -4.97M$ -3.73M$ -1.33M$ -3.38M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.07$ -0.15$ -0.28$ -0.12$ -1.02
Diluted EPS
$ -0.07$ -0.15$ -0.28$ -0.12$ -1.02
Weighted Average Shares Outstanding
51.13M 32.51M 13.38M 10.77M 3.30M
Weighted Average Shares Outstanding (Diluted)
51.13M 32.51M 13.38M 10.77M 3.30M
Currency in USD

Guided Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis